Erschienen in:
01.10.2014 | Editorial
On the need for comprehensive assessment of impact of comorbidity in elderly patients with head and neck cancer
verfasst von:
Afshin Teymoortash, Gyorgy B. Halmos, Carl E. Silver, Primož Strojan, Missak Haigentz Jr., Alessandra Rinaldo, Alfio Ferlito
Erschienen in:
European Archives of Oto-Rhino-Laryngology
|
Ausgabe 10/2014
Einloggen, um Zugang zu erhalten
Excerpt
Although a generally accepted definition of “elderly” still does not exist, in a medical context, persons over the age of 65 are often considered to be elderly. As life expectancy rates have increased within the last decades and continuously increase every year by approximately 3 months [
1], this segment of the population has increased, particularly in Western countries. Because cancer is a disease of aging, the risk of developing malignant disease including head and neck cancer is highest in this patient population. It also follows that malignancy-related mortality is highest among the elderly. …